Novel Therapy to Reverse the Cellular Effects of Bisphosphonates on Primary Human Oral Fibroblasts
- 31 October 2011
- journal article
- Published by Elsevier BV in Journal of Oral and Maxillofacial Surgery
- Vol. 69 (10), 2564-2578
- https://doi.org/10.1016/j.joms.2011.03.005
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Bisphosphonate osteonecrosis of the jaw—a literature review of UK policies versus international policies on bisphosphonates, risk factors and preventionBritish Journal of Oral and Maxillofacial Surgery, 2011
- Bisphosphonate effects on the behaviour of oral epithelial cells and oral fibroblastsArchives of Oral Biology, 2011
- Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial SurgeonsJournal of Bone and Mineral Metabolism, 2010
- Is Zoledronate Toxic to Human Periodontal Fibroblasts?Journal of Dental Research, 2009
- Pre-clinical Models for Oral and Periodontal Reconstructive TherapiesJournal of Dental Research, 2009
- Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate‐associated osteonecrosisBritish Journal of Haematology, 2009
- Frequency and Risk Factors Associated With Osteonecrosis of the Jaw in Cancer Patients Treated With Intravenous BisphosphonatesJournal of Bone and Mineral Research, 2008
- Inhibition of Oral Mucosal Cell Wound Healing by BisphosphonatesJournal of Oral and Maxillofacial Surgery, 2008
- Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?Bone, 2007
- Regulation of the mevalonate pathwayNature, 1990